{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:23:05Z","timestamp":1787865785339,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1097\/01.olq.0000170443.70739.cd","type":"journal-article","created":{"date-parts":[[2005,7,19]],"date-time":"2005-07-19T06:48:06Z","timestamp":1121755686000},"page":"495-498","source":"Crossref","is-referenced-by-count":44,"title":["A Study Evaluating Ceftriaxone as a Treatment Agent for Primary and Secondary Syphilis in Pregnancy"],"prefix":"10.1097","volume":"32","author":[{"given":"Pingyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiasheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanghuang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210213","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1093\/infdis\/174.Supplement_2.S223","article-title":"Successful eradication of sexually transmitted diseases in the People's Republic of China: implications for the 21st century.","volume":"174","author":"Cohen","year":"1996","journal-title":"J Infect Dis"},{"key":"R2-7-20210213","first-page":"1","article-title":"2003 Report on STD epidemic analysis in China.","volume":"18","year":"2004","journal-title":"Bull STI Prevent Control"},{"key":"R3-7-20210213","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/jama.1964.03060280080021","article-title":"Transplacental effect of tetracyclines on teeth.","volume":"188","author":"Kline","year":"1964","journal-title":"JAMA"},{"key":"R4-7-20210213","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4065\/74.7.727","article-title":"The tetracyclines.","volume":"74","author":"Smilack","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"R5-7-20210213","first-page":"492","article-title":"Congenital syphilis after maternal treatment with erythromycin.","volume":"47","author":"Fenton","year":"1976","journal-title":"Obstet Gynecol"},{"key":"R6-7-20210213","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007435-198301000-00008","article-title":"Erythromycin failure in the treatment of syphilis in a pregnant woman.","volume":"10","author":"Hashisaki","year":"1983","journal-title":"Sex Transm Dis"},{"key":"R7-7-20210213","first-page":"17","article-title":"Pharmacokinetic profile of ceftriaxone in man.","volume":"77","author":"Patel","year":"1984","journal-title":"Am J Med"},{"key":"R8-7-20210213","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/sti.79.5.415","article-title":"Treatment of neurosyphilis with ceftriaxone.","volume":"79","author":"Shann","year":"2003","journal-title":"Sex Transm Infect"},{"key":"R9-7-20210213","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/infdis\/158.4.881","article-title":"Ceftriaxone therapy for incubating and early syphilis.","volume":"158","author":"Hook","year":"1988","journal-title":"J Infect Dis"},{"key":"R10-7-20210213","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1086\/313725","article-title":"A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals.","volume":"30","author":"Marra","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R12-7-20210213","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1001\/jama.1986.03380180123032","article-title":"Intravenous penicillin desensitization and treatment during pregnancy.","volume":"256","author":"Ziaya","year":"1986","journal-title":"JAMA"},{"key":"R13-7-20210213","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1055\/s-2007-994332","article-title":"Penicillin desensitization in the treatment of syphilis during pregnancy.","volume":"14","author":"Chisholm","year":"1997","journal-title":"Am J Perinatol"},{"key":"R14-7-20210213","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0002-9378(16)37926-1","article-title":"The placental transfer of erythromycin.","volume":"69","author":"Kiefer","year":"1955","journal-title":"Am J Obstet Gynecol"},{"key":"R15-7-20210213","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJM197306072882307","article-title":"Transplacental passage of erythromycin and clindamycin.","volume":"288","author":"Philipson","year":"1973","journal-title":"N Engl J Med"},{"key":"R16-7-20210213","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1128\/AAC.44.3.806-807.2000","article-title":"A point mutation associated with bacterial macrolide resistance is present in both 23s rRNA genes of an erythromycin-resistant treponema pallidum clinical isolate.","volume":"44","author":"Stamm","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-7-20210213","first-page":"197","article-title":"Azithromycin treatment failures in syphilis infections: San Francisco, California, 2002\u20132003.","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R18-7-20210213","first-page":"188","article-title":"[Case control study of ceftriaxone in the treatment of early syphilis.]","volume":"30","author":"Zhou","year":"2001","journal-title":"J Clin Dermatol"},{"key":"R19-7-20210213","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/infdis\/165.2.396","article-title":"Evaluation of aqueous penicillin G and ceftriaxone for experimental neurosyphilis.","volume":"165","author":"Marra","year":"1992","journal-title":"J Infect Dis"},{"key":"R20-7-20210213","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000239106","article-title":"Maternal and fetal serum and tissue levels of ceftriaxone following preoperative prophylaxis in emergency cesarean section.","volume":"39","author":"Lang","year":"1993","journal-title":"Chemotherapy"},{"key":"R21-7-20210213","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/106002809302700306","article-title":"Ceftriaxone distribution and protein binding between maternal blood and milk postpartum.","volume":"27","author":"Bourget","year":"1993","journal-title":"Ann Pharmacother"},{"key":"R22-7-20210213","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/AAC.37.1.54","article-title":"Pharmacokinetics and protein binding of ceftriaxone during pregnancy.","volume":"37","author":"Bourget","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-7-20210213","first-page":"1","article-title":"1998 Guidelines for treatment of sexually transmitted diseases.","volume":"47","year":"1998","journal-title":"MMWR Recomm Rep"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.olq.0000170443.70739.cd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:54:44Z","timestamp":1785855284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007435-200508000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.olq.0000170443.70739.cd","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}